|
|
|
41
|
06926
|
NEOSTIGMINE 2.5MG/ML INJ (ANT) (BQ)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
10X1ML
|
BQ
|
46.21
|
4.6212
|
AMP
|
0
|
BOX
|
ANT
|
CONCORDIA INTERNATIONAL
|
COL
|
COLLINS LTD
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV/IM/SC
|
0
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
|
|
|
|
40
|
0692H
|
NEOSTIGMINE 2.5MG/ML INJ (SGH/COL)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
10X1ML
|
BQ
|
17.13
|
1.71
|
INJECTION
|
0
|
AMP
|
SGH
|
SEIGFRIED-HAMELN
|
COL
|
COLLINS LTD
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
40
|
0692J
|
LASTIGMINE 2.5MG/ML INJ (LDP/AHI)
|
NEOSTIGMINE
|
LASTIGMINE
|
5X1ML
|
BQ
|
16.99
|
3.40
|
INJECTION
|
0
|
AMP
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
2022-03-29
|
|
|
|
40
|
0692L
|
NEOSTIGMINE 2.5MG/ML INJ (MON/PHA)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
5X1ML
|
BQ
|
7.83
|
1.57
|
INJECTION
|
0
|
AMP
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
40
|
0694A
|
NEOSTIGMINE 2.5MG/ML INJ (MON/PHA)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
5X5ML
|
BQ
|
19.14
|
3.83
|
INJECTION
|
0
|
AMP
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
41
|
0694B
|
NEOSTIGMINE 2.5MG/ML INJ (OMG) (BQ)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
10X5ML
|
BQ
|
101.04
|
10.104
|
AMP
|
0
|
BOX
|
OMG
|
OMEGA
|
COL
|
COLLINS LTD
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2024-04-01
|
2024-07-19
|
|
IV
|
0
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2024-07-19
|
|
|
|
41
|
0694B
|
NEOSTIGMINE 2.5MG/ML INJ (OMG) (BQ)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
10X5ML
|
BQ
|
86.64
|
8.664
|
AMP
|
0
|
BOX
|
OMG
|
OMEGA
|
COL
|
COLLINS LTD
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2024-07-20
|
2026-03-31
|
|
IV
|
0
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2024-07-19
|
|
|
|
40
|
0694C
|
LASTIGMINE PLUS 2.5MG/ML INJ (LDP/AHI)
|
NEOSTIGMINE
|
LASTIGMINE PLUS
|
5X5ML
|
BQ
|
26.10
|
5.22
|
INJECTION
|
0
|
AMP
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
2022-03-29
|
|
|
|
41
|
0694C
|
LASTIGMINE PLUS 2.5MG/ML INJ (LDP) (BQ)
|
NEOSTIGMINE
|
LASTIGMINE PLUS
|
5X5ML
|
BQ
|
29.58
|
5.9151
|
AMP
|
0
|
BOX
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
|